|
(1) Intestinal Organoid Models for APC LOH
|
5R21CA208638-02
|
$192,406
|
GIARDINA, CHARLES
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
(10.) The Gut Microbiome and Responses to Neoadjuvant Chemoradiation in Rectal Cancer Patients
|
5R21CA205636-02
|
$202,275
|
CHEN, GRACE
|
UNIVERSITY OF MICHIGAN
|
|
(2/2) CDU/UCLA Cancer Center Partnership to Eliminate Cancer Health Disparities
|
5U54CA143930-08
|
$704,474
|
FARIAS-EISNER, ROBIN
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
(PQ1) GUCY2C hormone loss translates APC-Beta-catenin mutations into epithelial transformation
|
5R01CA206026-02
|
$356,850
|
WALDMAN, SCOTT
|
THOMAS JEFFERSON UNIVERSITY
|
|
(PQ10) Do microbiota alter the epigenetic landscape in human genome
|
5R21CA208464-02
|
$212,063
|
STRONGIN, ALEX
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
(PQ3) Immune Modulation of DNA Mismatch Repair in Colorectal Cancer
|
5R01CA206010-02
|
$369,639
|
CARETHERS, JOHN
|
UNIVERSITY OF MICHIGAN
|
|
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
|
5R01CA208756-02
|
$518,165
|
HACOHEN, NIR
|
BROAD INSTITUTE, INC.
|
|
(PQ5) Investigation of intertumoral and intratumoral heterogeneity of mitochondrial apoptotic sensitivity
|
5R01CA205967-02
|
$386,588
|
LETAI, ANTHONY
|
DANA-FARBER CANCER INST
|
|
(PQ6) Radiogenomics of colorectal polyps to assess benign proliferative vs. premalignant states.
|
1R01CA220004-01
|
$739,041
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
(PQA1)The Molecular Mechanisms Underlying Effects of Aspirin on Colorectal Cancer
|
5R01CA184820-04
|
$386,650
|
DUBOIS, RAYMOND
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
(PQB-4) Opposing Effects of the SASP in Cancer Progression
|
5R01CA184572-04
|
$329,925
|
HERBIG, UTZ
|
RBHS-NEW JERSEY MEDICAL SCHOOL
|
|
(PQB-4) Single cell analysis strategy for monitoring drug responses of tumors
|
5R01CA190122-04
|
$571,080
|
TIAN, QIANG
|
INSTITUTE FOR SYSTEMS BIOLOGY
|
|
(PQC-1) Driver Events In IBD-Associated Neoplastic Progression
|
5R01CA190040-04
|
$613,138
|
MELTZER, STEPHEN
|
JOHNS HOPKINS UNIVERSITY
|
|
(PQC1) Accelerated biological aging and colon polyp to cancer progression
|
5R01CA194663-03
|
$401,482
|
GRADY, WILLIAM
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
0021.0001 CG 425 METAVIVOR
|
261200800001E
|
$319,219,481
|
UNKNOWN, UNKNOWN
|
LEIDOS BIOMEDICAL RESEARCH, INC.
|
|
1/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132379-08
|
$1,258,708
|
MARTINEZ, MARIA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
1/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192973-04
|
$191,836
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
3P20CA192994-03S1
|
$63,140
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
1/2: Partnership to study racial/ethnic differences in GI cancer biology
|
5P20CA192994-03
|
$288,919
|
LI, ELLEN
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
15-Hydroxyprostaglandin Dehydrogenase, NSAIDs, Vitamin D, and Coloretcal Neoplasi
|
5U01CA181770-04
|
$507,599
|
LI, LI
|
CASE WESTERN RESERVE UNIVERSITY
|
|
15-LOX-1 Modulation of Colon Cancer Promotion by Linoleic Acid
|
5R01CA206539-02
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
15-LOX-1 Regulation of Resolving Generation to Modulate Colon Cancer
|
5R01CA195686-02
|
$366,000
|
SHUREIQI, IMAD
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
2/2 Partnership to Study Racial/Ethnic Differences in GI Cancer Biology
|
5P20CA192996-03
|
$154,908
|
MCCOMBIE, WILLIAM
|
COLD SPRING HARBOR LABORATORY
|
|
2/2 SDSU/UCSD Cancer Center Comprehensive Partnership
|
5U54CA132384-08
|
$1,192,222
|
ARREDONDO, ELVA
|
SAN DIEGO STATE UNIVERSITY
|
|
2/2 The Alabama State University/UAB Comprehensive Cancer Center Partnership
|
5P20CA192976-04
|
$144,556
|
MISHRA, MANOJ
|
ALABAMA STATE UNIVERSITY
|
|
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118623-12
|
$407,680
|
TROY, ROBERTA
|
TUSKEGEE UNIVERSITY
|
|
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
|
5U54CA118948-12
|
$1,170,535
|
MANNE, UPENDER
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
3D Dynamic Contrast-Enhanced US for Monitoring Chemotherapy of Liver Metastasis
|
5R01CA195443-02
|
$252,908
|
WILLMANN, JUERGEN
|
STANFORD UNIVERSITY
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
2U01CA164974-07
|
$2,195,369
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A Follow-up Study for Causes of Cancer in Black Women
|
5UM1CA164974-06
|
$639,740
|
ROSENBERG, LYNN
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
A multi-faceted approach to identifying K-Ras synthetic lethal relationships
|
5U01CA199252-03
|
$1,041,188
|
HAIGIS, KEVIN
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
A patient-centered intervention using virtual technology to reduce colorectal cancer disparities in primary care
|
1R01CA207689-01A1
|
$640,352
|
RAUP-KRIEGER, JANICE
|
UNIVERSITY OF FLORIDA
|
|
A PHASE I SINGLE-ARM, MULTICENTER PILOT STUDY AIMED AT VALIDATING Y-OHPDG AS A BIOMARKER AND TESTING THE EFFECTS OF POLYPHENON E ON ITS LEVELS IN PATIENTS WITH CIRRHOSIS
|
261201200035I
|
$2,834,664
|
UNKNOWN, UNKNOWN
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A scalable platform for target validation in GEMM models of gastrointestinal malignancies.
|
5R01CA195787-03
|
$641,206
|
LOWE, SCOTT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
5R21CA198237-02
|
$88,993
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
AARP prospective study of diet and cancer
|
ZIA CP010196-03152
|
$703,174
|
Sinha, Rashmi
|
DCEG (NCI)
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S1
|
$125,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-41S2
|
$62,491
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-41
|
$7,810,244
|
VONDERHEIDE, ROBERT
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accelerating Transdisciplinary Epidemiology of Colorectal Cancer
|
5R35CA197735-03
|
$869,969
|
OGINO, SHUJI
|
DANA-FARBER CANCER INST
|
|
Activatable molecular cancer imaging probe
|
ZIA BC 011512
|
$256,560
|
Kobayashi, Hisataka
|
CCR (NCI)
|
|
Adaptive Intervention to Maximize Colorectal Screening in Safety Net Populations
|
5R01CA188898-02
|
$621,534
|
GREINER, K
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
Adding patient and provider viewpoints to rectal cancer practice variation data
|
5K07CA197067-03
|
$142,021
|
CHARLTON, MARY
|
UNIVERSITY OF IOWA
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,629,581
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Advancing Virtual Colonoscopy for Early Cancer Screening
|
5R01CA206171-02
|
$439,539
|
LIANG, JEROME
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Age and Diet: Major interacting factors that drive sporadic intestinal cancer
|
5R01CA174432-05
|
$660,173
|
AUGENLICHT, LEONARD
|
ALBERT EINSTEIN COLLEGE OF MEDICINE, INC
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-04S1
|
$2,088,480
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-04
|
$11,145,123
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Altered Lipid Metabolism as a Novel Target for Colon Cancer Treatment
|
1R01CA208343-01A1
|
$425,312
|
EVERS, BERNARD
|
UNIVERSITY OF KENTUCKY
|
|
Aminooxyacetic Acid Prodrugs for Colon Cancer Therapy
|
1R41CA213463-01
|
$300,000
|
SZABO, CSABA
|
CBS THERAPEUTICS, INC.
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|